Details of the Drug
General Information of Drug (ID: DM7T3CU)
Drug Name |
4-Morpholin-4-yl-chromen-2-one
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-Morpholin-4-yl-chromen-2-one; 4-morpholin-4-ylchromen-2-one; CHEMBL367262; 65625-83-4; 4-morpholinyl coumarin; SMR000116476; AC1LFJN6; CBMicro_022351; Oprea1_628619; Oprea1_860966; MLS000526002; SCHEMBL11450752; 4-morpholino-2H-chromen-2-one; CTK1I2254; DTXSID30355510; MolPort-001-959-554; ZINC312514; HMS2490I17; CCG-9410; BDBM50159613; AKOS000639877; 4-(4-morpholinyl)-2H-chromen-2-one; MCULE-8859511318; BAS 01256112; BIM-0022285.P001; ST50008215; 2H-1-Benzopyran-2-one, 4-(4-morpholinyl)-; SR-01000312410; AI-204/31682008
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 231.25 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 1.4 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References